Hemp Ban Watch

October 27, 2026

Researchers Convert Hemp Waste Into Biodegradable Stem Cell Materials

Notable Scientists affiliated with universities in Spain and Ecuador have successfully transformed discarded hemp stems into hydrogels that support human stem cell growth, potentially opening new applications for industrial hemp in regenerative medicine, tissue engineering, and wound care. Published October 27 in *Discover Materials*, the study found that hemp-derived hydrogels achieved approximately 90% cell viability by day three of testing with adult human bone marrow-derived mesenchymal stem cells. The materials demonstrated a highly porous structure—approximately 78% porosity with more than 99% of pores interconnected—and absorbed roughly six times their dry weight in fluid after three hours, stabilizing at around 650% swelling capacity after 96 hours. While orange peel-derived hydrogels outperformed the hemp materials in some measures, researchers identified practical applications for both in wound dressings and tissue scaffolding, where their fluid absorption and cellular compatibility could prove valuable.

Meanwhile, the global cannabis industry faces sharply divergent regulatory directions. Brazil just crossed one million medical cannabis patients as of June 2026, and Latin America's largest cannabis fair, ExpoCannabis Brasil, expands its November 20–22 event to focus on hemp cultivation, industrial applications, and downstream industries—from construction materials to biotech and food. The expansion reflects Brazil's regulatory shift: after its Superior Court of Justice ordered the federal government and health regulator Anvisa to regulate hemp cultivation for medical and industrial use, Anvisa opened frameworks for controlled cultivation of plants with up to 0.3% THC and expanded research permissions. Market research firm Kaya Mind estimates the broader hemp market could reach R$51 billion annually under wider regulation, and the fair's program now includes agribusiness, hempcrete demonstrations, and institutional participation from Embrapa, Brazil's public agricultural research agency.

Uruguay, which legalized cannabis in 2013, takes a similar long-view approach at its 13th ExpoCannabis Uruguay fair on December 5–6, where sessions will address both neuroscience—cannabidiol's neuroprotective properties and cannabis in pediatric neurodevelopmental disorders—and the unsexy but critical business of club operations: payroll, taxes, and registration. Cait Curley, an industrial hemp expert from the U.S., will lead a live hempcrete demonstration, while Rosina Yemini will walk club operators through labor, tax, and administrative obligations including civil association registration with Uruguay's tax authority.

Money The contrast sharpens in the United States, where federal hemp-derived THC products face an existential regulatory threat. Articles from October 26–27 reference uncertainty for Minnesota breweries incorporating hemp THC, a federal hemp ban looming over the industry, and the beverage sector confronting what sources describe as an "existential threat." Brands are reportedly saying goodbye before a ban takes effect, and a backer of hemp regulation is now looking to reconciliation process as a potential legislative path forward. Willie Nelson's $200 million THC drinks brand and other companies have taken the extraordinary step of sending THC drinks to Congress to advocate for hemp regulation rather than prohibition.

Context The gap between regulatory frameworks reflects a broader pattern: countries developing hemp as an agricultural and industrial crop—with defined cultivation standards and medical applications—while the U.S. federal government weighs eliminating the legal market entirely, despite robust consumer adoption and zero recorded deaths from hemp-derived cannabinoids in human history.

October 26, 2026

European Union regulators are moving to standardize hemp cultivation and trade rules across all 27 member states, a significant shift toward creating uniform standards rather than fragmented national policies. The Council of the European Union last week approved a universal hemp framework as part of negotiations on the Common Organisation of the Markets, the EU's agricultural policy structure. The proposal would cover all parts of the hemp plant—including the flower—and allow farmers to monetize hemp beyond traditional fiber production, positioning the crop as more competitive and economically attractive across the bloc.

Money The framework maintains a 0.3% THC threshold while requiring all EU hemp to be grown from varieties registered in the Common Catalogue of Varieties of Agricultural Plant Species. By harmonizing these standards continent-wide, the Council aims to eliminate regulatory inconsistencies that currently create administrative friction and competitive disadvantages for farmers operating across borders. The move recognizes that fragmented hemp rules have created a patchwork market where producers in one member state face different compliance burdens than those in another, raising costs and limiting scale.

Context This regulatory alignment reflects a broader European trend: while some U.S. states continue to ban or restrict hemp-derived THC products—including smokable flower—the EU is moving in the opposite direction, expanding the plant's permitted uses and simplifying market access. The union's approach treats hemp as an agricultural commodity with legitimate economic value rather than a threat, and the standardized 0.3% THC ceiling provides public health guardrails without eliminating the plant's commercial potential.

The timing matters. As Willie Nelson's $200 million hemp-based THC drinks brand faces federal pressure in the United States, and Texas operators grapple with bans on smokable hemp products, the EU's move to broaden hemp cultivation opportunities and protect farmer revenue through standardized rules signals a diverging regulatory philosophy. The proposal still requires approval from the European Parliament, but the Council's support suggests momentum toward treating hemp as a normalized agricultural sector rather than a controlled substance.

October 25, 2026

Texas hemp industry wins a reprieve—but faces a narrowing legal path as courts and Congress wrestle with the future of THC products.

On May 1, 2026, Travis County District Court Judge Daniella DeSeta Lyttle issued a temporary injunction blocking Texas Department of State Health Services rules that would have banned smokable hemp across the state. The ruling extends through trial on July 27, keeping THCA flower, pre-rolls, and related products on shelves at retailers like Austin Cannabis Co. and the Austin-based D8 Austin dispensary. But the same morning, the Texas Supreme Court ruled in Sky Marketing Corp. v. DSHS that the health department does have authority to schedule synthetic cannabinoids like delta-8 and HHC—a door that could eventually swing shut on products that aren't naturally occurring in cannabis plants. None of those compounds have been banned yet, but the legal foundation is now in place. Context The distinction matters: naturally occurring trace THC is legal under the 2019 Texas Farm Bill, but the state is carving out a separate pathway to ban manufactured versions of compounds that hemp plants can produce.

The underlying conflict began when Gov. Greg Abbott issued an executive order in fall 2025, after the Texas Legislature spent months deadlocked on whether to regulate hemp products or ban them entirely. Acting on that order, DSHS finalized new rules in March that redefined "total THC" to include THCA—a cannabinoid that converts to delta-9 THC when heated. THCA flower, which accounts for over 70 percent of intoxicating hemp sales at some retailers, would no longer comply with the federal 0.3 percent delta-9 limit. The rules also raised licensing fees sharply: Money retail registration climbed from $150 to $5,000 annually and manufacturer registration from $250 to $10,000 annually—a 33 to 40 percent increase that industry leaders warned would force closures and cut jobs. Todd Harris, co-owner of Happy Cactus, told the court he was planning a third location if the injunction held but might have to shutter his east Austin store if it didn't. Kenneth Burner, who runs Burner's Vape, Smoke and Herb in Galveston County and employs 10 people including veterans and military families, expressed concern that legal consumers would be pushed into unregulated markets.

The federal picture is equally volatile. Most hemp-derived THC products remain protected until December 11, 2026, when a congressional extension expires—and the outcome depends on negotiations that have shifted from simple delay tactics to actual regulatory design. Rep. Beth Van Duyne, a Texas Republican, is pushing the White House to adopt a regulated framework for hemp-derived THC beverages modeled on alcohol rules: age restrictions, taxation, serving limits, marketing controls, and a ban on synthetic cannabinoids. Rep. Morgan Griffith is openly calling for compromise around third-party testing and a broader regulatory structure rather than outright prohibition. But opposition remains organized—Rep. Andy Harris, who helped drive the 2025 federal restrictions, is openly opposing efforts to build a new legal market and is calling for the ban to take effect as scheduled.

The stakes extend beyond boardrooms to veterans and medical users. Many service members rely on legal THC products for PTSD, chronic pain, and anxiety, and state bans force them toward either unlicensed markets or prescription opioids. The interstate shipping question remains legally murky: federal law permits hemp-derived products that meet the 0.3 percent delta-9 standard to cross state lines, but Texas courts have not directly addressed whether consumers can legally receive shipments. A federal judge denied an emergency restraining order on August 10, and a preliminary injunction motion remains pending with no public hearing date scheduled.

Meanwhile, the Texas hemp litigation tracker shows both state and federal cases in motion, each with different timelines and potential outcomes. The July 27 trial date will determine whether the injunction survives, while federal negotiations continue toward December. Money The industry collectively faces a question: stay and fight in court, or start scaling back operations before the deadline. For now, Texas hemp retailers are restocking and selling legally while they can—but operating under the assumption that this window may close.

October 24, 2026

Texas hemp retailers are operating in a legal whipsaw created by conflicting court rulings and aggressive state enforcement that has fundamentally reshaped the market since May 2026. The Texas Department of State Health Services (DSHS) is now actively enforcing two overlapping sets of restrictions: a July 31 ban on manufactured delta-8, delta-10, THCP, and other synthetic THC isomers classified as Schedule I controlled substances, and a "Total THC Rule" that counts naturally occurring THCA as 88 percent of Delta-9 THC when heated—effectively removing most smokable hemp flower from legal sale. The restrictions followed a Texas Supreme Court ruling in May that allowed DSHS to revive dormant 2021 definitions, ending a five-year injunction that had kept these products legal while litigation moved forward.

Money The financial consequences are immediate and severe. DSHS raised retailer registration fees from $150 to $5,000 annually and manufacturer fees from $250 to $10,000, while enforcement letters have gone out to retailers carrying products that previously passed state testing. The timing has created a contradiction within the industry itself: the Texas Hemp Business Council, the lead plaintiff fighting the restrictions in court, is largely funded by Hometown Hero, an Austin-based retailer and manufacturer founded by CEO Lukas Gilkey that does not sell smokable flower—effectively positioning a major industry player to profit from competitors' inventory becoming illegal. A Travis County judge temporarily blocked the smokable hemp restrictions in May, but the Fifteenth Court of Appeals reversed that order in June, putting enforcement back in play while litigation continues through the state court system.

The new rules target products that retailers began selling after Texas legalized hemp in 2019 under House Bill 1325, which only explicitly banned products with more than 0.3 percent Delta-9 THC by dry weight. DSHS interpreted that statute as implicitly prohibiting manufactured cannabinoid variants like delta-8 (which can be chemically derived from hemp-derived CBD) while grandfathering in naturally occurring trace amounts—a distinction the state has been deliberately vague about. Hemp businesses argue DSHS has exceeded its statutory authority by adopting restrictions that the Texas Legislature never explicitly enacted, a position that will determine whether products currently on retail shelves remain legal or face confiscation.

Context The Texas Supreme Court's reasoning in Sky Marketing Corp. v. DSHS left the legal door open for DSHS to eventually schedule HHC, THCV, THCJD, and other cannabinoids—a broad authority that retailers say transforms the marketplace through administrative rulemaking rather than legislative action. The court didn't rule on whether these restrictions are wise policy, only that the agency had the authority to make them. What remains unresolved is whether DSHS acted within the actual language of Texas law or whether it created new prohibitions administrators were never empowered to make—a question that will likely reach the appellate courts again before 2026 closes.

The hemp market in Texas has become a test case for how states manage the gap between federal hemp legalization and state-level resistance to intoxicating cannabis products. As of October 2026, retailers remain in legal limbo, with enforcement accelerating, court rulings continuing to reverse each other, and the industry's own leadership divided on strategy. DSHS has signaled it's moving forward with enforcement despite ongoing litigation, leaving businesses to navigate inventory decisions, supplier testing protocols, and compliance documentation based on rules that multiple courts have already blocked once. The outcome will likely determine whether other states follow Texas's aggressive reinterpretation approach or whether the courts ultimately force regulators back to the explicit language of the hemp statute.